Please ensure Javascript is enabled for purposes of website accessibility
top of page

Transforming Patient Access to High-Cost, One-Time Treatments through Financial Engineering Innovation

August 26, 2024 at 12:30 pm US EDT


Self-insured employers collectively cover over 120 million lives in the United States. Many of these employers face challenges in providing coverage that ensures patient access to high-cost treatments for ultra-rare diseases. This presentation will guide the audience through the current issues and explore how alternative commercialization strategies could help expand patient access within the employer market.



Yutong Sun is the co-founder and CEO of Quantile Health, a gene therapy access platform company. She previously served as the lead data scientist at Oscar Health, a Google-backed healthcare insurance startup. Prior to that, she worked as a quant trader at Virtu Financial. Yutong's background, combining financial engineering and insurance, gives her a unique opportunity to innovate in healthcare through data-driven approaches.





39 views

Comments


bottom of page